Request to Join
has invited you to join this group
Less than
left
Left
Begins in
less than
Begins in
Ended
Ongoing
Following our OncLive® webinars focused on myelofibrosis, Bart Scott, MD, addresses unanswered questions from the audience surrounding treatment options in myelofibrosis.
Less than
left
Left
Begins in
less than
Begins in
Ended
Ongoing
This discussion centers on using checkpoint inhibitors to manage squamous cell carcinoma of the head and neck (SCCHN).
Less than
left
Left
Begins in
less than
Begins in
Ended
Ongoing
This discussion will focus on patients with HPV-positive OPSCC who are eligible to receive a de-escalation therapy.
Less than
left
Left
Begins in
less than
Begins in
Ended
Ongoing
Based on data revealed during the 2019 SGO Annual Meeting, experts in gynecologic oncology remark on the utilization of targeted therapy for the treatment of patients with epithelial ovarian cancer. Please join us for an installment of our Ask the Experts series as we further...